A Randomised, Double-blind, Placebo-controlled, Proof-of-mechanism Phase 2 Trial Investigating the Effect of Quinagolide Extended-release Vaginal Ring on Reduction of Lesions Assessed by High-resolution Magnetic Resonance Imaging in Women With Endometrioma, Deep Infiltrating Endometriosis, and/or Adenomyosis
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2019
Price : $35 *
At a glance
- Drugs Quinagolide (Primary)
- Indications Adenomyosis; Endometriosis
- Focus Therapeutic Use
- Acronyms QLARITY
- Sponsors Ferring Pharmaceuticals
- 25 Mar 2019 Planned initiation date changed from 1 Mar 2019 to 1 May 2019.
- 15 Feb 2019 Planned initiation date changed from 1 Feb 2019 to 1 Mar 2019.
- 04 Feb 2019 Planned End Date changed from 1 Nov 2020 to 1 Dec 2020.